ZBH - Zimmer Biomet Holdings, Inc.
NEXT EARNINGS:
May 4, 2026
EPS Est: $1.86
|
Rev Est: $2.1B
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$107.82
DETAILS
HIGH:
$130.00
LOW:
$89.00
MEDIAN:
$110.00
CONSENSUS:
$107.82
UPSIDE:
7.96%
Market Cap:
19.79B
Volume:
1,151,165
Avg Volume:
2,227,606
52 Week Range:
84.59-114.44
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
0.61
Last Dividend:
$0.96
Exchange:
NYSE
Country:
US
Employees:
17,000
IPO Date:
2001-07-25
EPS (TTM):
3.56
P/E Ratio:
25.25
Revenue (TTM):
8.23B
Total Assets:
23.09B
Total Debt:
7.52B
Cash & Equiv:
591.90M
Rev Growth (5Y):
6.1%
EPS Growth (5Y):
10.0%
FCF Growth (5Y):
6.2%
ROCE:
5.5%
Debt/Equity:
0.59
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-10 | $2.42 | $2.38 | +1.7% | $2.2B | $2.1B | +8.7% |
| 2025-11-05 | $1.90 | $1.87 | +1.6% | $2.0B | $2.0B | -0.5% |
| 2025-08-07 | $2.07 | $1.98 | +4.5% | $2.1B | $2.1B | +1.0% |
| 2025-05-05 | $1.81 | $1.77 | +2.3% | $1.9B | $1.9B | +0.7% |
| 2025-02-06 | $2.31 | $2.30 | +0.4% | $2.0B | $2.0B | +0.4% |
| 2024-10-30 | $1.74 | $1.74 | 0.0% | $1.8B | $1.8B | +1.4% |
| 2024-08-07 | $2.01 | $1.99 | +1.0% | $1.9B | $1.9B | +0.1% |
| 2024-05-02 | $1.94 | $1.87 | +3.7% | $1.9B | $1.9B | +1.2% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.23B | 7.68B | 7.39B | 6.94B | 6.83B | 6.13B | 7.98B | 7.93B | 7.80B | 7.67B | 6.00B | 4.67B |
| Net Income | 705.20M | 903.80M | 1.02B | 231.40M | 401.60M | (138.90M) | 1.13B | (379.20M) | 1.81B | 305.90M | 147.00M | 720.30M |
| EPS | 3.56 | 4.45 | 4.91 | 1.10 | 1.93 | -0.67 | 5.52 | -1.86 | 9.11 | 1.51 | 0.27 | 4.26 |
| Total Assets | 23.09B | 21.37B | 21.50B | 21.07B | 23.46B | 24.42B | 24.64B | 24.13B | 26.01B | 26.68B | 27.16B | 9.63B |
| Total Debt | 7.52B | 6.20B | 5.77B | 5.70B | 7.07B | 8.13B | 8.22B | 8.94B | 10.14B | 11.24B | 11.50B | 1.43B |
| Cash & Equivalents | 591.90M | 525.50M | 415.80M | 375.70M | 378.10M | 802.10M | 617.90M | 542.80M | 524.40M | 634.10M | 1.46B | 1.08B |
| Operating Cash Flow | 1.70B | 1.50B | 1.58B | 1.28B | 1.50B | 1.20B | 1.59B | 1.75B | 1.58B | 1.63B | 862.80M | 1.05B |
| Free Cash Flow | 1.47B | 1.14B | 1.19B | 1.07B | 1.35B | 1.09B | 1.18B | 1.58B | 1.43B | 1.45B | 682.10M | 915.60M |
| FCF per Share | 7.44 | 5.63 | 5.69 | 5.09 | 6.46 | 5.28 | 5.76 | 7.79 | 7.06 | 7.24 | 3.64 | 5.42 |
| Book Value | 12.71B | 12.47B | 12.48B | 12.02B | 12.66B | 12.19B | 12.39B | 11.27B | 11.74B | 9.67B | 9.89B | 6.55B |
| Cash & ST Investments | 591.90M | 525.50M | 415.80M | 375.70M | 378.10M | 802.10M | 617.90M | 542.80M | 524.40M | 634.10M | 1.62B | 1.70B |
| ROC Equity | 0.06 | 0.07 | 0.08 | 0.02 | 0.03 | -0.01 | 0.09 | -0.03 | 0.15 | 0.03 | 0.01 | 0.11 |